Remote monitoring program for ADHD in rural children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The RAMP program is a pilot initiative aimed at evaluating the feasibility of a remote monitoring system for children aged 5-11 diagnosed with ADHD in rural areas. This study will enroll 36 caregiver-child dyads across two sites, where participants will be randomized to either receive text-based symptom reporting prompts or standard digital education handouts. The program includes ADHD Best Practice education for providers and utilizes the Vanderbilt Rating Scales for symptom assessment. The study will last for 10 months, focusing on the implementation and engagement of the monitoring program rather than clinical outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

The child must

* be under the care of a participating provider
* be aged 5-11 at enrollment
* have a diagnosis of ADHD
* be initiating stimulant medication for treatment for the first time or have not received stimulant medication for the last 6 months
* be attending in-person elementary school

The Primary caregiver must

* be willing and legally able to give consent
* have access to a smartphone
* be English-speaking
* reside with the child at least 3 days per week
* complete an initial symptom assessment prior to starting stimulant treatment and be willing to provide a copy to the study team

The provider must

* manage ADHD care in patients age 5-11 years
* provide informed consent
* agree to use the RAMP platform if they care for patients randomized to use it
* agree to provide information to potential participants about the study and contact the research coordinator if interested

Exclusion Criteria:

Child:

* has serious mental health comorbidities (Children with depression, anxiety, oppositional defiant disorder will be permitted to participate. Children with schizophrenia, bipolar disorder, conduct disorder and those who have been hospitalized for any mental health condition will be excluded from the study.)
* has severe neurodevelopment disorders (Children with well-controlled seizure disorders will be permitted to participate.)
* is currently receiving, or previously received, atypical antipsychotic medication treatment
* is or becomes pregnant

Where it's running

• University of Mississippi Medical Center
  Jackson, Mississippi, United States Recruiting
• Medical University of South Carolina
  Charleston, South Carolina, United States Recruiting

Study contacts

• Study coordinator: Song Ounpraseuth, PhD
• Email: STOunpraseuth@uams.edu
• Phone: 501-686-7233

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biomarkers that predict medication-related side effects in children with ADHD

  This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.

  Recruiting National Taiwan University Hospital · Taipei, Taiwan · NCT07900451

• Group CBT vs. Activity Group for Adults with ADHD

  This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.

  Recruiting at 2 sites Region Stockholm · Stockholm and 1 other locations · NCT07834437

• Central Executive Training and Behavioral Parent Training for Young Children with ADHD

  This study tests Central Executive Training (CET) alone and CET combined with Behavioral Parent Training (BPT) to help young children with ADHD.

  Recruiting Florida State University · Tallahassee, Florida · NCT07784348

• Augmenting Parent Management Training with a Smartphone Tool

  This study tests whether adding a smartphone app to parent management training helps reduce irritability and temper outbursts in kids aged 8–13 with disruptive behavior disorders.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07764536

• Centanafadine in adults with ADHD and emotional dysregulation

  This study tests centanafadine XR once daily to see if it helps adults with ADHD who also have emotional dysregulation.

  Recruiting at 16 sites Phase 3 Otsuka Pharmaceutical Development & Commercialization, Inc. · Gainesville, Florida and 15 other locations · NCT07759154

• Solriamfetol for ADHD in teens: see if it helps with focus

  This phase 3 study tests solriamfetol versus placebo in adolescents with ADHD to see if the medication improves symptoms over 6 weeks.

  Recruiting at 31 sites Phase 3 Axsome Therapeutics, Inc. · Dothan, Alabama and 30 other locations · NCT07717892

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.